Respiratory Syncytial Virus (RSV) Clinical Trials

A listing of Respiratory Syncytial Virus (RSV) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
Featured trial
Respiratory Syncytial Virus (RSV) Vaccine

Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and above.

vaccination
  • 0 views
  • 18 Oct, 2021
  • 1 location
Featured trial
Respiratory Syncytial Virus (RSV) Vaccine

will be a global study that will span multiple RSV seasons.

  • 0 views
  • 18 Oct, 2021
  • 1 location
Featured trial
RSV Vaccine

Clinical Study Center (AMR Ft. Myers) is currently enrolling in an investigational RSV vaccine clinical research study.

  • 3 views
  • 08 Apr, 2021
  • 1 location
Featured trial
Regeneron RSV Trial

Regeneron RSV Trial

  • 95 views
  • 08 Nov, 2020
  • 1 location
A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection

The purpose of this study is to evaluate the efficacy of rilematovir compared to placebo with respect to the time to resolution of respiratory syncytial virus (RSV) lower respiratory tract

  • 4 views
  • 29 Dec, 2021
  • 190 locations
A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

episode of RSV-associated lower respiratory tract disease (RSV-LRTD) as compared with placebo from 14 days postinjection through 12 months.

Accepts healthy volunteers
  • 0 views
  • 21 Jan, 2022
  • 3 locations
A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Syncytial Virus (RSV) disease, compared to adults 65 years and above.

Accepts healthy volunteers
  • 0 views
  • 02 Jan, 2022
  • 21 locations
A Study of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to Less Than 65 Years

The purpose of this study is to demonstrate non-inferiority in terms of humoral immune responses of Ad26.RSV.preF-based study vaccine lots representative of different aged vaccine in comparison to a non-aged Ad26.RSV.preF-based study vaccine lot.

  • 0 views
  • 16 Jan, 2022
  • 8 locations
Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.

This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of RSVpreF in the prevention of moderate to severe LRTI-RSV in

Accepts healthy volunteers
  • 65 views
  • 19 Jan, 2022
  • 165 locations
Arbidol for COPD Exacerbations

viruses including respiratory syncytial disease (RSV), parainfluenza virus, human rhinovirus, coxsackie virus (CV), adenovirus (ADV) and so on. In recent years, some fundamental and clinical researches

  • 0 views
  • 23 Jan, 2021
  • 1 location